← Open Payments lookup

ALISON BERLENBACH: Open Payments

NPI 1063187730 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 40 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,299 · 2025 $1,514

Food & beverage: $1,437Education: $77
CompanyPaymentsAmount
Madrigal Pharmaceuticals12$454
ABBVIE INC.12$369
Aimmune Therapeutics, Inc.1$124
PFIZER INC.2$122
Intercept Pharmaceuticals, Inc.1$111
QOL Medical, LLC4$107
Janssen Biotech, Inc.2$100
Takeda Pharmaceuticals U.S.A., Inc.4$79
GENZYME CORPORATION1$29
Braintree Laboratories, Inc.1$17

Products named: REZDIFFRA, LINZESS, RINVOQ, ZENPEP, VELSIPITY, OCALIVA, Sucraid, TREMFYA.

Industry payments across DC — which companies pay providers there.